BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 18/10/2022

FDA Releases Draft Guidance for Industry on Immune-Mediated Adverse Reactions in Cancer Immunotherapeutic Clinical Trials

The FDA is releasing a draft guidance for industry on how to characterize, collect, and report immune-mediated adverse reactions in cancer immunotherapeutic clinical trials, aiming to improve the assessment of adverse events in cancer treatments.

Source: Federal Register — Food and Drug AdministrationOpen original release →